Corxel Pharmaceuticals
Boston, United States· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $287M
Overview
A small molecule drug discovery company targeting oncology and immunology with a proprietary chemistry platform.
OncologyImmunology
Technology Platform
A proprietary chemistry platform focused on synthesizing small molecules that modulate challenging intracellular targets like protein-protein interactions.
Funding History
1Total raised:$287M
Series D$287M
Opportunities
Successful validation of its platform with a clinical candidate could lead to a lucrative partnership or platform licensing deal with a large pharma.
Risk Factors
High risk of platform failure or inability to generate a clinical candidate with a competitive profile in a reasonable timeframe.
Competitive Landscape
Faces intense competition from numerous other small molecule discovery platforms and companies pursuing similar targets in oncology and immunology.